These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21212066)

  • 1. Predicting the future of genetic risk prediction.
    Chatterjee N; Park JH; Caporaso N; Gail MH
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):3-8. PubMed ID: 21212066
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations.
    van Zitteren M; van der Net JB; Kundu S; Freedman AN; van Duijn CM; Janssens AC
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):9-22. PubMed ID: 21212067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polygenic risk prediction of common diseases: from epidemiology to clinical application].
    Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tiny step closer to personalized risk prediction for breast cancer.
    Devilee P; Rookus MA
    N Engl J Med; 2010 Mar; 362(11):1043-5. PubMed ID: 20237351
    [No Abstract]   [Full Text] [Related]  

  • 5. Genome-wide association studies and the clinic: a focus on breast cancer.
    Véron A; Blein S; Cox DG
    Biomark Med; 2014; 8(2):287-96. PubMed ID: 24521025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of genome-wide association studies (GWAS) on breast cancer and application values of single nucleotide polymorphisms identified from GWAS].
    Huang Y; Song F; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Oct; 36(10):1058-61. PubMed ID: 26837343
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
    Baker SG
    J Natl Cancer Inst; 2007 Mar; 99(6):487-8; author reply 488-9. PubMed ID: 17374838
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
    Ambrosone CB; Shields PG; Freudenheim JL; Hong CC
    J Natl Cancer Inst; 2007 Mar; 99(6):487; author reply 488-9. PubMed ID: 17374839
    [No Abstract]   [Full Text] [Related]  

  • 9. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNPs associated with molecular subtypes of breast cancer: on the usefulness of stratified Genome-wide Association Studies (GWAS) in the identification of novel susceptibility loci.
    Kristensen VN; Børresen-Dale AL
    Mol Oncol; 2008 Jun; 2(1):12-5. PubMed ID: 19383324
    [No Abstract]   [Full Text] [Related]  

  • 11. The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer.
    Ambrosone CB
    Breast Cancer Res; 2007; 9(6):114. PubMed ID: 18096087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and breast cancer risk prediction--are we there yet?
    Cook NR; Paynter NP
    J Natl Cancer Inst; 2010 Nov; 102(21):1605-6. PubMed ID: 20956781
    [No Abstract]   [Full Text] [Related]  

  • 13. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
    Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
    Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new susceptibility locus for estrogen receptor-negative breast cancer.
    Maduro MR
    Reprod Sci; 2012 Jan; 19(1):5. PubMed ID: 22228736
    [No Abstract]   [Full Text] [Related]  

  • 15. Previous GWAS hits in relation to young-onset breast cancer.
    Shi M; O'Brien KM; Sandler DP; Taylor JA; Zaykin DV; Weinberg CR
    Breast Cancer Res Treat; 2017 Jan; 161(2):333-344. PubMed ID: 27848153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic model for predicting breast cancer risk via genome-wide polymorphisms.
    Piccolo SR; Camp N; Frey LJ
    AMIA Annu Symp Proc; 2008 Nov; ():1094. PubMed ID: 18999159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
    Hunter DJ; Kraft P; Jacobs KB; Cox DG; Yeager M; Hankinson SE; Wacholder S; Wang Z; Welch R; Hutchinson A; Wang J; Yu K; Chatterjee N; Orr N; Willett WC; Colditz GA; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Hayes RB; Tucker M; Gerhard DS; Fraumeni JF; Hoover RN; Thomas G; Chanock SJ
    Nat Genet; 2007 Jul; 39(7):870-4. PubMed ID: 17529973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer.
    Pepe MS; Janes HE
    J Natl Cancer Inst; 2008 Jul; 100(14):978-9. PubMed ID: 18612128
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
    Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
    BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
    Yanes T; Young MA; Meiser B; James PA
    Breast Cancer Res; 2020 Feb; 22(1):21. PubMed ID: 32066492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.